Replies to post #205752 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Interesting price target. There are many here who feel a buyout would happen at a much higher value.

Really hard to value for me. I would be disappointed getting anything less than your target.

[Mellowmood77]

Last thing is the BB. They should report around the 15th. That could give us more clues. If they sell some it will hurt the stock. If they buy more or hold it will help the price and give us some assurance. I feel that could be the last possible negative event before label expansion.

Baker Brother's hold more than 5% of the float. As such, they need to report within 10 days if their change in ownership deviated by more than 1%. They file this in a 13D. (They recently did this with MRTX).

10 days after the closing of the offering is Monday. If they were a buyer you will know tomorrow. If you don't hear anything tomorrow, they didn't sell or buy more than 1% of their holdings.

A lot of people are talking about the offering. This is NORMAL business in small bio-tech. Do a simple google search and you can find MANY biotechs that issue a secondary before FDA approval of an NDA/SNDA. I can think of 3 off the top of my head: AGIO, SAGE, SRPT.

This board has gone over many of the reasons they needed to issue the secondary. I believe it's for EVERY reason. Full blitz on advertising, hiring new sales force, ramping up supply, etc etc. My favorite is ramping up supply... from TerraPharma:

n which case, they'll be using a decent chunk of the newly raised cash to stockpile V for Eddingpharm to use in 2021. #logistics #vascepa #eddingpharm $AMRN ??